美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA212309"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
68001-517-36 68001-517 HUMAN PRESCRIPTION DRUG fosaprepitant fosaprepitant INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20210823 20240731 ANDA ANDA212309 BluePoint Laboratories FOSAPREPITANT DIMEGLUMINE 150 mg/5mL 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-517-36) / 5 mL in 1 VIAL, SINGLE-DOSE
69097-830-37 69097-830 HUMAN PRESCRIPTION DRUG fosaprepitant fosaprepitant INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20190905 N/A ANDA ANDA212309 Cipla USA Inc. FOSAPREPITANT DIMEGLUMINE 150 mg/5mL 1 VIAL, SINGLE-DOSE in 1 CARTON (69097-830-37) / 5 mL in 1 VIAL, SINGLE-DOSE
71839-104-01 71839-104 HUMAN PRESCRIPTION DRUG fosaprepitant fosaprepitant INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20191015 N/A ANDA ANDA212309 BE Pharmaceuticals Inc. FOSAPREPITANT DIMEGLUMINE 150 mg/5mL 1 VIAL, SINGLE-DOSE in 1 CARTON (71839-104-01) / 5 mL in 1 VIAL, SINGLE-DOSE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase